Q1 - Q2 '16 NEAR-TERM CATALYSTS Many have seen the past

New Post Public Reply Private Reply Replies (0) Message Board
INSTATRADER
Q1 - Q2 '16 NEAR-TERM CATALYSTS

Many have seen the past 30 days or so come and go with low volume, and wonder if all has been priced in or the fun is over..... NOT EVEN CLOSE

The start of Q1 '16 - the end of Q2 '16 will bring this share price close to another 5 BAGGER from these levels. HERES HOW....

First lets rehash what got us to the point we are now....
On 12/9/15 the company PAID OFF a total of $2.4M in debt. That represents ALL OF ITS AGED DEBT! There is NONE on the balance sheet. That took us to an O/S of ~350M .
http://www.otcmarkets.com/stock/RXMD/news/Pro...99&b=y

On 1/6/16 The company submitted its ATTORNEY LETTER with respect to current information...A step towards Yield sign removal .
http://www.otcmarkets.com/financialReportView...;id=149416

On 1/7/16 The company released its annual letter to shareholders which went over accomplishments achieved in '15, and stated goals for '16. This validated the letter issued last year, as the goals stated were achieved...
http://www.otcmarkets.com/stock/RXMD/news/Pro...24&b=y

On 1/8/16 The company officially had the yield sign removed...
http://www.otcmarkets.com/stock/RXMD/news/Pro...24&b=y

On 1/14/16 The company announced a record 180K prescriptions filled in '15...A RECORD...
http://www.otcmarkets.com/stock/RXMD/news/Pro...74&b=y

Each and every announcement here solidified an already solid company by quieting the critics who didnt believe what they were seeing... It also allowed many to truly understand the path we are headed......

The following CATALYSTS have yet to bear fruit, and these next 2 quarters will bear them out:

1) MTM REVENUE .... First mentioned here:
http://www.otcmarkets.com/stock/RXMD/news/Pro...83&b=y

"PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016."

This revenue, is not simply a margin spreading catalyst...It also allows for a greater universe of patients, as well as an opportunity to consolidate ALL OF THEIR PRESCRIPTIONS in 1 PHARMACY! Thats a big difference! And they will see increase revenue from EXISTING patients!

2) 340B CONTRACT(S)
" Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. " THAT IS NOW

3) PALM BEACH COUNTY EXPANSION

" Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. "
What this actually means, is they are entering some of the busiest doctor offices who actually asked them to come in and fill their prescription needs, as other pharmacies were not getting it done right......Think about the lines, you see at a "good doctors office" and think about ALL THOSE PRESCRIPTIONS

4) NON-DEAL ROAD SHOW
http://www.otcmarkets.com/stock/RXMD/news/Pro...26&b=y

One thing this company has not done, is expose itself to UNREAL EXPECTATIONS (this company doesnt even put its news out on the wires)

It is quite safe to say, that as in the case of the debt payoff - The company is being QUITE CONSERVATIVE in its dealings here...First, the company would NEVER put out a PR about this non-deal roadshow, if it really wasnt TRULY IMPRESSIVE....Since this roadshow the shareprice has more than DOUBLED!

5) NEW ROBOTIC DISPENSING SYSTEM
At first glance it doesnt seem like much of a deal. Blah blah but it IS! The robot doesnt need a lunch break, it doesnt need a salary, or benefits...it GREATLY improves margins, and with 180K prescriptions at $86/prescription there will be more cash available for our next item:

6) M&A
This is my greatest catalyst for 2016...The company mentioned in its letter to shareholders that expansion and "MAJOR" growth are on the way for '16. Every CEO says that, but lets not forget they hit EACH AND EVERY TARGET in '15. This company, and COO have a long history of successfull straight, and reverse mergers under their belt, and after my call to ARMEN a month back, they are ACTIVELY LOOKING for acquisitions. This is the first quarter where the cash flow will be truly large, and with all this uncertainty in the economy right now, there are several targets, and areas they can access that were unavailable just a few short months ago. When you acquire a pharmacy, or health services company, you are acquiring a revenue producing MACHINE, and as of now PHARMCO is in the drivers seat where they can pick and choose who they go to bed with.


I only mentioned items that are PROVABLE, there are a few left I will not get into as they are more conjecture than fact.

Only fact left is that RXMD will see a share price no les than .10 by the end of Q2...Mark this post.

Good luck to all fellow longs who along with me have this float on LOCKDOWN

Progressive Care Inc. (RXMD) Stock Research Links

RXMD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Union Pacific Faces $98.8 Million Arbitration Tab

Updated Category News Views 181

A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 100

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 48

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 103

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 61

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading

Top 5 Most Recently Viewed Articles

The Hiring Crisis for Gen Z: Understanding Key Economic Factors

Updated Category News Views 472

The Hiring Crisis for Gen Z In today's economy, young Americans, particularly those under 25, are experiencing a significant challenge in securing employment. This issue, marked by increasing unemployment rates among recent graduates, is creating alarm. Most agree that the factors influencing this crisis point to a stagnation in hiring practices rather than advancements...

Continue Reading
Recent Class Action Highlights Concerns Around Bumble Inc. Shares

Updated Category News Views 78

Understanding the Recent Class Action Against Bumble Inc. The landscape of online dating and social networking continues to evolve, with Bumble Inc. playing a significant role in shaping user experiences. Recently, a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against Bumble Inc. (BMBL). This...

Continue Reading
Analyzing Li Auto Inc's Market Sentiment and Short Interest

Updated Category News Views 165

Understanding Market Sentiment for Li Auto Inc Li Auto Inc (NYSE: LI) has recently witnessed a noteworthy shift in its short interest percentage. As reported, the company’s short interest has decreased by 13.66%, with approximately 20.65 million shares being sold short. This figure represents about 5.12% of the total shares that are available for trading. The data...

Continue Reading
Equity Markets Take a Breather During Holiday Pause

Updated Category News Views 245

Markets Hold Steady as Investors Reflect With the US markets taking a break for the Thanksgiving holiday, global equities have collectively paused for a moment of reflection. This calmness among investors is primarily influenced by current expectations regarding a dovish shift in Federal Reserve policy. Speculation is high, with many assigning about an 80% probability for...

Continue Reading
University of Phoenix's New Leadership in Counseling: What’s Next?

Updated Category News Views 358

New Leadership Spotlight: Yurandol Thompson Elevated The University of Phoenix has gone and done it again, appointing Yurandol Thompson as Associate Dean for Counseling, effective January 29, 2026. Now, this isn’t just any old shake-up. Dr. Thompson brings over a decade of experience in clinical operations and programmatic excellence. I mean, come on—sounds impressive...

Continue Reading